FDA draft guidance on transdermal systems [BE/BA News]

posted by Ohlbe – France, 2023-04-13 10:37 (242 d 01:08 ago) – Posting: # 23523
Views: 855

Dear all,

If you're working on transdermal and topical delivery systems, you will be interested in two new FDA draft guidance documents:
- one on the assessment of irritation and sensitisation potential;
- one on the assessment of adhesion.
—
Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,823 posts in 4,786 threads, 1,633 registered users;
28 visitors (0 registered, 28 guests [including 4 identified bots]).
Forum time: 10:46 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5